StockData
Cadrenal Therapeutics, Inc. logo

Cadrenal Therapeutics, Inc. (CVKD) stock

CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.72−0.16 (-8.51%)

Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%

Cadrenal Therapeutics cash

Cash and short-term investments held at the end of each period.

Cadrenal Therapeutics's cash was $2.39M at Jun 30, 2026. For fiscal 2025 it was $4.01M, down 60.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.01M-60.0%
FY2024Dec 31, 2024$10.02M+19.2%
FY2023Dec 31, 2023$8.40M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.39M-57.1%
Q1 FY2026Mar 31, 2026$2.31M-68.5%
Q4 FY2025Dec 31, 2025$4.01M-60.0%
Q3 FY2025Sep 30, 2025$3.86M-11.5%
Q2 FY2025Jun 30, 2025$5.57M+10.6%
Q1 FY2025Mar 31, 2025$7.34M+11.7%
Q4 FY2024Dec 31, 2024$10.02M+19.2%
Q3 FY2024Sep 30, 2024$4.36M-52.1%
Q2 FY2024Jun 30, 2024$5.04M+25.0%
Q1 FY2024Mar 31, 2024$6.57M–
Q4 FY2023Dec 31, 2023$8.40M–
Q3 FY2023Sep 30, 2023$9.11M–
Q1 FY2023Mar 31, 2023$4.03M–

More Cadrenal Therapeutics figures

See a number that looks wrong?